Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8345 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8121 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8054 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8042 |
Intermediate Similarity |
NPD3764 |
Approved |
0.8025 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8015 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7935 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7862 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7799 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7673 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7632 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7532 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7529 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5403 |
Approved |
0.75 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7228 |
Approved |
0.745 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7432 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD37 |
Approved |
0.7391 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7389 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7383 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7378 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7362 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7358 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7346 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7301 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7292 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7244 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7235 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7219 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7213 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7208 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7181 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7174 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7171 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD1933 |
Approved |
0.717 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7999 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7127 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7127 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7122 |
Intermediate Similarity |
NPD969 |
Suspended |
0.7119 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD9493 |
Approved |
0.711 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7107 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7089 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7076 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7049 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7049 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7049 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7049 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7049 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7049 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7049 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7041 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7034 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7034 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7019 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7018 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7016 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7007 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD7584 |
Approved |
0.6984 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6984 |
Remote Similarity |
NPD7874 |
Approved |
0.6957 |
Remote Similarity |
NPD2533 |
Approved |
0.6957 |
Remote Similarity |
NPD2532 |
Approved |
0.6957 |
Remote Similarity |
NPD2534 |
Approved |
0.6948 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6947 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6947 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6939 |
Remote Similarity |
NPD1535 |
Discovery |
0.6936 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6935 |
Remote Similarity |
NPD7697 |
Approved |
0.6935 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6935 |
Remote Similarity |
NPD7698 |
Approved |
0.6931 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6923 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD5494 |
Approved |
0.6923 |
Remote Similarity |
NPD3748 |
Approved |
0.6918 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6914 |
Remote Similarity |
NPD6273 |
Approved |
0.6913 |
Remote Similarity |
NPD3225 |
Approved |
0.6906 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6906 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6898 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6898 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6892 |
Remote Similarity |
NPD1608 |
Approved |
0.6892 |
Remote Similarity |
NPD3972 |
Approved |
0.689 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD9494 |
Approved |
0.6883 |
Remote Similarity |
NPD943 |
Approved |
0.6882 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6878 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD2797 |
Approved |
0.6863 |
Remote Similarity |
NPD3268 |
Approved |
0.6863 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6855 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6849 |
Remote Similarity |
NPD9268 |
Approved |
0.6835 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD2344 |
Approved |
0.6835 |
Remote Similarity |
NPD2353 |
Approved |
0.6832 |
Remote Similarity |
NPD7236 |
Approved |
0.6824 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD2798 |
Approved |
0.6815 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6815 |
Remote Similarity |
NPD1238 |
Approved |
0.6813 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6809 |
Remote Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD8407 |
Phase 2 |
0.6797 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6797 |
Remote Similarity |
NPD7095 |
Approved |
0.6795 |
Remote Similarity |
NPD6653 |
Approved |
0.6793 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD3226 |
Approved |
0.6786 |
Remote Similarity |
NPD5353 |
Approved |
0.6784 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6784 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6779 |
Remote Similarity |
NPD9717 |
Approved |
0.6774 |
Remote Similarity |
NPD1613 |
Approved |
0.6774 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6772
|
Remote Similarity |
NPD5404 |
Approved |